$ALSN
Allison Transmission Holdings Inc

2013 Q2 Form 10-Q Financial Statement

#000119312513310167 Filed on July 30, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $512.1M $559.4M
YoY Change -8.46% 0.67%
Cost Of Revenue $286.0M $307.5M
YoY Change -6.99% -1.16%
Gross Profit $226.1M $251.9M
YoY Change -10.24% 3.03%
Gross Profit Margin 44.15% 45.03%
Selling, General & Admin $85.60M $109.1M
YoY Change -21.54% 12.71%
% of Gross Profit 37.86% 43.31%
Research & Development $22.80M $23.20M
YoY Change -1.72% -16.25%
% of Gross Profit 10.08% 9.21%
Depreciation & Amortization $50.10M $62.80M
YoY Change -20.22% -1.57%
% of Gross Profit 22.16% 24.93%
Operating Expenses $108.4M $132.3M
YoY Change -18.07% 6.27%
Operating Profit $117.7M $119.6M
YoY Change -1.59% 0.0%
Interest Expense -$37.30M -$39.80M
YoY Change -6.28% -45.4%
% of Operating Profit -31.69% -33.28%
Other Income/Expense, Net -$2.600M -$22.80M
YoY Change -88.6% -412.33%
Pretax Income $81.80M $62.70M
YoY Change 30.46% -659.82%
Income Tax $31.30M $384.8M
% Of Pretax Income 38.26% 613.72%
Net Earnings $50.50M $412.8M
YoY Change -87.77% -2500.0%
Net Earnings / Revenue 9.86% 73.79%
Basic Earnings Per Share $0.27 $2.28
Diluted Earnings Per Share $0.26 $2.21
COMMON SHARES
Basic Shares Outstanding 185.9M shares 181.4M shares
Diluted Shares Outstanding 189.9M shares 186.4M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $227.4M $112.1M
YoY Change 102.85%
Cash & Equivalents $227.4M $112.1M
Short-Term Investments
Other Short-Term Assets $31.10M $62.60M
YoY Change -50.32%
Inventory $162.9M $168.3M
Prepaid Expenses
Receivables $208.5M $234.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $686.6M $577.8M
YoY Change 18.83%
LONG-TERM ASSETS
Property, Plant & Equipment $563.3M $581.3M
YoY Change -3.1%
Goodwill $1.941B
YoY Change
Intangibles $1.661B
YoY Change
Long-Term Investments
YoY Change
Other Assets $84.70M $172.8M
YoY Change -50.98%
Total Long-Term Assets $4.251B $4.486B
YoY Change -5.24%
TOTAL ASSETS
Total Short-Term Assets $686.6M $577.8M
Total Long-Term Assets $4.251B $4.486B
Total Assets $4.938B $5.064B
YoY Change -2.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $168.4M $186.2M
YoY Change -9.56%
Accrued Expenses $82.50M $90.50M
YoY Change -8.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $23.50M $8.000M
YoY Change 193.75%
Total Short-Term Liabilities $414.0M $409.6M
YoY Change 1.07%
LONG-TERM LIABILITIES
Long-Term Debt $2.786B $3.013B
YoY Change -7.54%
Other Long-Term Liabilities $188.9M $358.0M
YoY Change -47.23%
Total Long-Term Liabilities $2.974B $3.371B
YoY Change -11.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $414.0M $409.6M
Total Long-Term Liabilities $2.974B $3.371B
Total Liabilities $3.509B $3.780B
YoY Change -7.18%
SHAREHOLDERS EQUITY
Retained Earnings -$157.7M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $200.0K
YoY Change
Treasury Stock Shares
Shareholders Equity $1.429B $1.284B
YoY Change
Total Liabilities & Shareholders Equity $4.938B $5.064B
YoY Change -2.49%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $50.50M $412.8M
YoY Change -87.77% -2500.0%
Depreciation, Depletion And Amortization $50.10M $62.80M
YoY Change -20.22% -1.57%
Cash From Operating Activities $129.7M $106.9M
YoY Change 21.33% 27.57%
INVESTING ACTIVITIES
Capital Expenditures -$13.20M -$34.80M
YoY Change -62.07% 117.5%
Acquisitions
YoY Change
Other Investing Activities $1.700M $200.0K
YoY Change 750.0% -99.45%
Cash From Investing Activities -$11.50M -$34.60M
YoY Change -66.76% -270.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.80M -170.3M
YoY Change -88.37% -8.54%
NET CHANGE
Cash From Operating Activities 129.7M 106.9M
Cash From Investing Activities -11.50M -34.60M
Cash From Financing Activities -19.80M -170.3M
Net Change In Cash 98.40M -98.00M
YoY Change -200.41% 19.37%
FREE CASH FLOW
Cash From Operating Activities $129.7M $106.9M
Capital Expenditures -$13.20M -$34.80M
Free Cash Flow $142.9M $141.7M
YoY Change 0.85% 41.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
115400000
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
60700000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
314000000
CY2012Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
113600000
CY2012Q1 us-gaap Deferred Revenue
DeferredRevenue
61200000
CY2012Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
43400000
CY2012Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
111100000
CY2012Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
33900000
CY2012Q2 us-gaap Deferred Revenue
DeferredRevenue
63600000
CY2012Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
77200000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112100000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
42600000
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
14200000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
19500000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
377800000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43900000
CY2012Q4 us-gaap Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent
DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent
200000
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
109700000
CY2012Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
34600000
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7500000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47500000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2801300000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11300000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1601500000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
133100000
CY2012Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
36200000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
213800000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1356900000
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
63500000
CY2012Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
52900000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-202300000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21600000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
73500000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
900000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
2801300000
CY2012Q4 us-gaap Liabilities
Liabilities
3509100000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
167400000
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
834900000
CY2012Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
6900000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4866000000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
100000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
90100000
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-200000
CY2012Q4 us-gaap Goodwill
Goodwill
1941000000
CY2012Q4 us-gaap Derivative Assets
DerivativeAssets
200000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1716100000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
165000000
CY2012Q4 us-gaap Inventory Net
InventoryNet
157100000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
24500000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
55300000
CY2012Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
5000000
CY2012Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
80600000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
200000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
596200000
CY2012Q4 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
870000000
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
32300000
CY2012Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
80200000
CY2012Q4 us-gaap Assets
Assets
4866000000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80200000
CY2012Q4 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
75200000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32700000
CY2012Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
44500000
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
6100000
CY2012Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3657100000
CY2012Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2551000000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
490300000
CY2012Q4 alsn Defense Price Reduction Reserve
DefensePriceReductionReserve
12000000
CY2012Q4 alsn Vendor Buyback Obligation
VendorBuybackObligation
13900000
CY2012Q4 alsn Assets And Liabilities Fair Value Disclosure
AssetsAndLiabilitiesFairValueDisclosure
33600000
CY2012Q4 alsn Assets Held In Trusts
AssetsHeldInTrusts
200000
CY2012Q4 alsn Amount Of Collateral Recorded In Other Current Assets
AmountOfCollateralRecordedInOtherCurrentAssets
3000000
CY2012Q4 alsn Sales Allowances
SalesAllowances
27000000
CY2012Q4 alsn Long Term Debt Current And Non Current
LongTermDebtCurrentAndNonCurrent
2820800000
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
40200000
CY2013Q2 us-gaap Interest Payable Current
InterestPayableCurrent
15200000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
23500000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
414000000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-53000000
CY2013Q2 us-gaap Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent
DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent
800000
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
105600000
CY2013Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
33400000
CY2013Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2841900000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33300000
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2785500000
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8200000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1638000000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
168400000
CY2013Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
35800000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
188900000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
1429000000
CY2013Q2 us-gaap Deferred Revenue
DeferredRevenue
61100000
CY2013Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
36900000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-157700000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21300000
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
69800000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1200000
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
2785500000
CY2013Q2 us-gaap Liabilities
Liabilities
3508800000
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
165000000
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
889900000
CY2013Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
8300000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4937800000
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
10400000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
84700000
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
98800000
CY2013Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-2000000
CY2013Q2 us-gaap Goodwill
Goodwill
1941000000
CY2013Q2 us-gaap Derivative Assets
DerivativeAssets
0
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1661100000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
208500000
CY2013Q2 us-gaap Inventory Net
InventoryNet
162900000
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
97100000
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
30300000
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
89700000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
56700000
CY2013Q2 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
5000000
CY2013Q2 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
79000000
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
200000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
563300000
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
87200000
CY2013Q2 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
870000000
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1100000
CY2013Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
227400000
CY2013Q2 us-gaap Assets
Assets
4937800000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
227400000
CY2013Q2 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
222400000
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
31100000
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8100000
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
92400000
CY2013Q2 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
45500000
CY2013Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
9600000
CY2013Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3602100000
CY2013Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2551000000
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
275500000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
686600000
CY2013Q2 alsn Research And Development Payable
ResearchAndDevelopmentPayable
3100000
CY2013Q2 alsn Defense Price Reduction Reserve
DefensePriceReductionReserve
28000000
CY2013Q2 alsn Vendor Buyback Obligation
VendorBuybackObligation
9700000
CY2013Q2 alsn Assets And Liabilities Fair Value Disclosure
AssetsAndLiabilitiesFairValueDisclosure
200100000
CY2013Q2 alsn Assets Held In Trusts
AssetsHeldInTrusts
800000
CY2013Q2 alsn Amount Of Collateral Recorded In Other Current Assets
AmountOfCollateralRecordedInOtherCurrentAssets
1700000
CY2013Q2 alsn Sales Allowances
SalesAllowances
25800000
CY2013Q2 alsn Ownership Percentage By Related Parties
OwnershipPercentageByRelatedParties
0.810 pure
CY2013Q2 alsn Achieved Senior Secured Leverage Ratio
AchievedSeniorSecuredLeverageRatio
3.50 pure
CY2013Q2 alsn Long Term Debt Current And Non Current
LongTermDebtCurrentAndNonCurrent
2809000000
CY2013Q2 alsn Achieved Total Leverage Ratio
AchievedTotalLeverageRatio
4.28 pure
CY2013Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
107500000
CY2013Q1 us-gaap Deferred Revenue
DeferredRevenue
61600000
alsn Grant Program Income
GrantProgramIncome
44000000
dei Entity Central Index Key
EntityCentralIndexKey
0001411207
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Trading Symbol
TradingSymbol
ALSN
dei Entity Registrant Name
EntityRegistrantName
ALLISON TRANSMISSION HOLDINGS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTE A.&#xA0;OVERVIEW</b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Overview</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Allison Transmission Holdings, Inc. and its subsidiaries (the &#x201C;Company&#x201D; or &#x201C;Allison&#x201D;), design and manufacture commercial and defense fully-automatic transmissions.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The business was founded in 1915 and has been headquartered in Indianapolis, Indiana since inception. The Company has 12 different transmission product lines. Although approximately 78% of revenues were generated in North America in 2012, the Company has a global presence by serving customers in Europe, Asia, South America and Africa. The Company serves customers through an independent network of approximately 1,400 independent distributor and dealer locations worldwide.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Since the introduction of the Company&#x2019;s first fully-automatic transmission over 60 years ago, the Company&#x2019;s products have gained acceptance in a wide variety of applications, including on-highway trucks (distribution, refuse, construction, fire and emergency), buses (principally school, transit and hybrid-transit), motorhomes, off-highway vehicles and equipment (principally energy, mining and construction) and defense vehicles (wheeled and tracked). The Company has developed over 100 different product models that are used in more than 2,500 different vehicle configurations, which are compatible with more than 500 combinations of engine brands, models and ratings. The Company also sells support equipment and Allison-branded replacement parts for the Company&#x2019;s transmissions and remanufactured transmissions for use in the vehicle aftermarket.</font></p> </div>
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
188900000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3600000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.382 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
184400000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Significant estimates include, but are not limited to, allowance for doubtful accounts, sales allowances, government price adjustments, fair market values and future cash flows associated with goodwill, indefinite life intangibles, long-lived asset impairment tests, useful lives for depreciation and amortization, warranty liability, determination of discount and other assumptions for pension and other postretirement benefit expense, income taxes and deferred tax valuation allowances, derivative valuation, and contingencies. The Company&#x2019;s accounting policies involve the application of judgments and assumptions made by management that include inherent risks and uncertainties. Actual results could differ materially from these estimates. Changes in estimates are recorded in results of operations in the period that the events or circumstances giving rise to such changes occur.</font></p> </div>
us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-2400000
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
8100000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
100000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
7000000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
14100000
us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
1600000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185300000 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25800000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
15700000
us-gaap Payments Of Dividends
PaymentsOfDividends
33400000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
13300000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3000000
us-gaap Investment Income Interest
InvestmentIncomeInterest
400000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
126200000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
11800000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
969500000
us-gaap Interest Paid
InterestPaid
79600000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3100000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
44200000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
22900000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1900000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
68900000
us-gaap Gross Profit
GrossProfit
424400000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2500000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
200000
us-gaap Operating Income Loss
OperatingIncomeLoss
199100000
us-gaap Payments To Acquire Projects
PaymentsToAcquireProjects
6300000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1600000
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-8300000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5700000
us-gaap Net Income Loss
NetIncomeLoss
78000000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7800000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9100000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
800000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
545100000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
49000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17700000
us-gaap Marketable Securities Realized Gain Loss Other Than Temporary Impairments Amount
MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount
2500000
us-gaap Share Based Compensation
ShareBasedCompensation
7700000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
147200000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
173500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48200000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
11100000
us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
2500000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
35600000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
200000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
20300000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25200000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4700000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
7000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
55000000
us-gaap Depreciation
Depreciation
49700000
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
10500000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30600000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51800000
alsn Different Product Models
DifferentProductModels
100 Product
alsn Accretion For Predecessor Liability
AccretionForPredecessorLiability
400000
alsn Grant Program Income
GrantProgramIncome
3200000
alsn Independent Distributor And Dealer In Worldwide Locations
IndependentDistributorAndDealerInWorldwideLocations
1400 Customer
alsn Reduction Of Basis Of Capital Assets Purchased Under Grant Program
ReductionOfBasisOfCapitalAssetsPurchasedUnderGrantProgram
2700000
alsn Transmission Product Lines
TransmissionProductLines
12 Product
alsn Combinations Of Engine Brands Models And Ratings
CombinationsOfEngineBrandsModelsAndRatings
500 Brand
alsn Year Of Introduction Of Company Automatic Products
YearOfIntroductionOfCompanyAutomaticProducts
P60Y
alsn Interest Expenses
InterestExpenses
67600000
alsn Different Vehicle Configurations
DifferentVehicleConfigurations
2500 Vehicle
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
200000
alsn Assets In Service Under Grant Program
AssetsInServiceUnderGrantProgram
7100000
alsn Depreciation Related To Grant Program
DepreciationRelatedToGrantProgram
100000
alsn Public Offering Fees And Expenses
PublicOfferingFeesAndExpenses
600000
alsn Increase Decrease In Collateral For Interest Rate Derivatives
IncreaseDecreaseInCollateralForInterestRateDerivatives
-1300000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.55
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
184400000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3000000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
2.227 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
246500000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181400000 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
62500000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
10300000
us-gaap Payments Of Dividends
PaymentsOfDividends
10900000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
14500000
us-gaap Income Taxes Paid
IncomeTaxesPaid
6400000
us-gaap Investment Income Interest
InvestmentIncomeInterest
600000
us-gaap Early Repayment Of Subordinated Debt
EarlyRepaymentOfSubordinatedDebt
326900000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
145900000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
45500000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1161300000
us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-1000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2500000
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
12800000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
10100000
us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
2300000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-21100000
us-gaap Interest Paid
InterestPaid
88800000
us-gaap Defined Benefit Plan Other Changes
DefinedBenefitPlanOtherChanges
-2300000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42000000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
15100000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
469500000
us-gaap Gross Profit
GrossProfit
535700000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
3000000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4600000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
75000000
CY2012Q2 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-1700000
CY2012Q2 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
7300000
us-gaap Operating Income Loss
OperatingIncomeLoss
274300000
us-gaap Payments To Acquire Projects
PaymentsToAcquireProjects
8000000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-200000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-53600000
us-gaap Net Income Loss
NetIncomeLoss
470800000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14200000
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-16000000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
625600000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-330800000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-388100000
us-gaap Marketable Securities Realized Gain Loss Other Than Temporary Impairments Amount
MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount
8000000
us-gaap Share Based Compensation
ShareBasedCompensation
3500000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-201900000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Transition Asset Obligation Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax
2300000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
210300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-324900000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
9700000
us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
8000000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
23900000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
400000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
22200000
us-gaap Depreciation
Depreciation
49900000
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
9900000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70000000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51100000
alsn Accretion For Predecessor Liability
AccretionForPredecessorLiability
400000
alsn Grant Program Income
GrantProgramIncome
4100000
alsn Reduction Of Basis Of Capital Assets Purchased Under Grant Program
ReductionOfBasisOfCapitalAssetsPurchasedUnderGrantProgram
2200000
alsn Interest Expenses
InterestExpenses
75400000
alsn Depreciation Related To Grant Program
DepreciationRelatedToGrantProgram
300000
alsn Public Offering Fees And Expenses
PublicOfferingFeesAndExpenses
6100000
alsn Increase Decrease In Collateral For Interest Rate Derivatives
IncreaseDecreaseInCollateralForInterestRateDerivatives
-100000
CY2011 alsn Percentage Of Annual Excess Cash Flow For Pre Payment Of Loan
PercentageOfAnnualExcessCashFlowForPrePaymentOfLoan
0.00 pure
CY2012 alsn Percentage Of Annual Excess Cash Flow For Pre Payment Of Loan
PercentageOfAnnualExcessCashFlowForPrePaymentOfLoan
0.50 pure
CY2013Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
2500000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.28
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.21
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
186400000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5000000 shares
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
5.584 pure
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
181400000 shares
CY2012Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
7400000
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
300000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
62700000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
559400000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000
CY2012Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
4800000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
404600000
CY2012Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7600000
CY2012Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
384800000
CY2012Q2 us-gaap Defined Benefit Plan Other Changes
DefinedBenefitPlanOtherChanges
-2300000
CY2012Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3700000
CY2012Q2 us-gaap Gross Profit
GrossProfit
251900000
CY2012Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
3200000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
119600000
CY2012Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-300000
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22800000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
412800000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
50500000
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
286000000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
85600000
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
307500000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
109100000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-350100000
CY2012Q2 us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
8000000
CY2012Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
13300000
CY2012Q2 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
4900000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23200000
CY2012Q2 alsn Accretion For Predecessor Liability
AccretionForPredecessorLiability
200000
CY2012Q2 alsn Grant Program Income
GrantProgramIncome
1300000
CY2012Q2 alsn Reduction Of Basis Of Capital Assets Purchased Under Grant Program
ReductionOfBasisOfCapitalAssetsPurchasedUnderGrantProgram
700000
CY2012Q2 alsn Interest Expenses
InterestExpenses
34400000
CY2012Q2 alsn Depreciation Related To Grant Program
DepreciationRelatedToGrantProgram
200000
CY2012Q2 alsn Public Offering Fees And Expenses
PublicOfferingFeesAndExpenses
400000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189900000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4000000 shares
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.383 pure
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185900000 shares
CY2013Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
7800000
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
200000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81800000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
512100000
CY2013Q2 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-500000
CY2013Q2 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
4800000
CY2013Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
7400000
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2500000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31300000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44000000
CY2013Q2 us-gaap Gross Profit
GrossProfit
226100000
CY2013Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
500000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
117700000
CY2013Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1000000
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2600000
CY2013Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
10400000
CY2013Q2 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
5300000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22800000
CY2013Q2 alsn Accretion For Predecessor Liability
AccretionForPredecessorLiability
200000
CY2013Q2 alsn Grant Program Income
GrantProgramIncome
2000000
CY2013Q2 alsn Reduction Of Basis Of Capital Assets Purchased Under Grant Program
ReductionOfBasisOfCapitalAssetsPurchasedUnderGrantProgram
1300000
CY2013Q2 alsn Interest Expenses
InterestExpenses
33500000
CY2013Q2 alsn Depreciation Related To Grant Program
DepreciationRelatedToGrantProgram
0
CY2013Q2 alsn Public Offering Fees And Expenses
PublicOfferingFeesAndExpenses
600000

Files In Submission

Name View Source Status
0001193125-13-310167-index-headers.html Edgar Link pending
0001193125-13-310167-index.html Edgar Link pending
0001193125-13-310167.txt Edgar Link pending
0001193125-13-310167-xbrl.zip Edgar Link pending
alsn-20130630.xml Edgar Link completed
alsn-20130630.xsd Edgar Link pending
alsn-20130630_cal.xml Edgar Link unprocessable
alsn-20130630_def.xml Edgar Link unprocessable
alsn-20130630_lab.xml Edgar Link unprocessable
alsn-20130630_pre.xml Edgar Link unprocessable
d552917d10q.htm Edgar Link pending
d552917dex1027.htm Edgar Link pending
d552917dex1028.htm Edgar Link pending
d552917dex311.htm Edgar Link pending
d552917dex312.htm Edgar Link pending
d552917dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g552917g03r43.jpg Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R57.htm Edgar Link pending
R57.xml Edgar Link unprocessable
R58.htm Edgar Link pending
R58.xml Edgar Link unprocessable
R59.htm Edgar Link pending
R59.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R60.htm Edgar Link pending
R60.xml Edgar Link unprocessable
R61.htm Edgar Link pending
R61.xml Edgar Link unprocessable
R62.htm Edgar Link pending
R62.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending